Hazard
410 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 410 particulate matter recalls we have scored against our rubric, 57 (14%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 186 (45%) are Severe.
Which agencies issued them
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all particulate matter recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
Hospira is recalling 86,400 ampuls of 5% Lidocaine HCl and 7.5% Dextrose Injection due to reports of visible particulates in the glass ampules.
Hospira Inc. is recalling 283,150 vials of Propofol Injectable Emulsion because visible particulate matter was found embedded in the glass vials during inspection.
Hospira is recalling 264,432 bags of 0.9% Sodium Chloride Injection because the product may contain fibrous material.
Nexus Pharmaceuticals is recalling 46,185 vials of Benztropine Mesylate Injection due to the presence of glass delamination flakes.
Hospira is recalling 94,110 vials of Propofol Injectable Emulsion because a single stainless steel particulate was found during inspection.
Sandoz Incorporated is recalling specific lots of Methotrexate Injection vials because particulate matter was found in retention samples.
Hospira Inc. is recalling 0.9% Sodium Chloride Injection, USP, 1000 mL containers due to the presence of small grey/brown brass particulates.
Hospira is recalling 340,600 vials of Ondansetron Injection due to the discovery of particulate matter in a preceding lot.
Hospira is recalling 268,700 vials of Sodium Chloride Injection, USP, 0.9% due to a confirmed report of visible particulate matter embedded in the plastic vial.
Pharmalucence, Inc. is recalling Technetium Tc 99m Sestamibi Injection kits due to the presence of particulate matter found in retained samples.
Hospira Inc. is recalling 168,300 vials of Gentamicin Sulfate Injection USP 80 mg/2 mL because visible particles were found floating in the primary container.
Pharmacia & Upjohn LLC is recalling specific lots of Cleocin Phosphate injection vials due to the presence of very small reflective flakes consistent with glass delamination.
Gilead Sciences is recalling Vistide (cidofovir) injection vials because particulate matter was found in some units. The recall covers 3,181 vials distributed in the US, Canada, and UK.
Hospira Inc. is recalling 245,250 vials of Propofol Injectable Emulsion because a single visible particulate was found during a retain sample inspection.
Hospira Inc. is recalling 68,020 vials of Propofol Injectable Emulsion, 1%, due to the presence of visible particulate matter.
Hospira Inc. is recalling 273,925 vials of Propofol Injectable Emulsion because visible particulate matter was found during inspection.
Bracco Diagnostic Inc. is recalling specific lots of Isovue-370 injection syringes because they contain particulate matter, including cellulose and polyvinyl fibers.
Bracco Diagnostic Inc. is recalling specific lots of Isovue-300 Injection syringes because they contain particulate matter identified as cellulose and polyvinyl fibers.
Custom Healthcare Systems is recalling 80 breast biopsy trays because they may contain particulate matter in the pharmaceuticals used for injection.
Custom Healthcare Systems is recalling breast biopsy trays because they may contain particulate matter in the included sodium chloride.
Merit Medical Systems is recalling 422 Custom Procedural Trays and Kits because of particulate matter found in the 0.9% Sodium Chloride Injection.
Physicians Total Care is recalling Procrit (epoetin alfa) injection vials because of glass delamination and particulate matter. The recall affects 20 vials distributed in Pennsylvania and California.
Hospira is recalling Lidocaine Hydrochloride Injection vials because visible particulate matter embedded in the glass wall may dislodge into the product.
Bracco Diagnostic Inc is recalling Choletec kits because they may contain particulate matter, including potential charcoal particulates.
Ben Venue Laboratories is recalling 226,010 vials of Leucovorin Calcium Injection due to the presence of visible crystalline particulates.